[Alcoholic and non-alcoholic steatohepatitis].

Area of Science:

• Hepatology
• Gastroenterology
• Internal Medicine

Background:

• Chronic alcohol abuse leads to alcoholic steatohepatitis (ASH), a condition that can rapidly progress to cirrhosis.
• Increasing rates of obesity and metabolic syndrome are driving a rise in non-alcoholic steatohepatitis (NASH).
• Clinical differentiation between ASH and NASH can be difficult, complicating diagnosis and treatment.

Purpose of the Study:

• To highlight the challenges in distinguishing between alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH).
• To emphasize the importance of identifying underlying causes for effective treatment strategies.
• To discuss diagnostic methods and differing therapeutic approaches for ASH and NASH.

Main Methods:

• Utilizing CAGE questions and family interviews to detect potential alcohol abuse.
• Liver biopsy to identify histological features of fatty liver, hepatocyte necrosis, and inflammation.
• Comparing clinical presentations and diagnostic limitations for ASH and NASH.

Main Results:

• Histological examination reveals similar features for both ASH and NASH, including fatty liver, necrosis, and inflammation.
• Despite histological similarities, distinct pathogenetic mechanisms are implied.
• Accurate diagnosis is essential as treatment strategies differ significantly between ASH and NASH.

Conclusions:

• Alcohol abstinence is the primary treatment for alcoholic steatohepatitis (ASH).
• Reducing insulin resistance through weight loss is the cornerstone of managing non-alcoholic steatohepatitis (NASH).
• Effective management requires accurate differentiation between ASH and NASH, despite diagnostic challenges.